Abstracts

Citation

Edmund Capparelli, Pharm.D., Sandra K. Burchett, M.D., M.S., Andrea Kovacs, M.D., Margaret Khoury, M.D., Vincent J. Carey, Ph.D., Elizabeth (Betsy) Smith, M.D., Lynne M. Mofenson, M.D., F.A.A.P., James D. Connor, M.D., Bonnie Zimmer, B.S., Elizabeth Hawkins. Nelfinavir (NFV) Pharmacokinetics In Combination With Ritonavir (RTV) In Infants and Children With Advanced HIV Disease.

Citation

Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Brookie M. Best, Pharm.D., Alice M. Stek, M.D., ChengCheng Hu, Ph.D., Edmund Capparelli, Pharm.D., Diane Holland, M.Phil., Sandra K. Burchett, M.D., M.S., Elizabeth (Betsy) Smith, M.D., Mark Mirochnick, M.D. Nelfinavir pharmacokinetics (625 mg tablets) during the third trimester of pregnancy and post-partum. Presented at: 14th Conference on Retroviruses and Opportunistic Infections.

Citation

Mark Mirochnick, M.D., Karin Alvarenga-Hyldgaard Nielsen, M.D., M.P.H., Jose Henrique Pilotto, M.D., Jorge Pinto, M.D., D.Sc., Valdilea V. Santos, M.D., Ph.D., Diane Holland, M.Phil., Heather D. Watts, M.D., John ( Jack ) Moye, Jr., M.D., Lynne M. Mofenson, M.D., F.A.A.P., Yvonne J. Bryson, M.D. Nelfinavir pharmacokinetics with an increased dose during the first two weeks of life. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

Janet Ailene Englund, M.D., Claire Raskino, M.S., Ross E. McKinney, Jr., M.D., Deborah Pearson, Ph.D., Carol J. Baker, M.D. Neurocognitive/Neurological Outcomes in HIV-Infected Children Receiving Different Nucleoside Antiretroviral Regimens.

Citation

Michael Boivin, Alla Sikorskii, Jim Aizire, Limbika Maliwichi-Senganimalunje, Lillian Wambuzi Ogwang, Newton Kumwenda, Itziar Familiar, Horacio Escudero-Ruisenoir, Taha Taha, Mary Glenn Fowler. Neurodevelopment of Ugandan and Malawian PROMISE and Control children at age 12 and 24 months. Presented at: CROI 2016.

Citation

Michael Boivin, Lillian Wambuzi, Rachel Kawalazira, Limbika Maliwichi-Senganimalunje, Alla Sikorskii, Itziar Familiar-Lopez, Agatha Kuteesa, Mary Nyakato, Alex Mutebe, Mai Nakitende, MacPherson Mallewa, Horacio Ruisefior-Escudero, Jim Aizire, Taha Taha, Mary Glenn Fowler. Neurodevelopmental effects of type of antepartum and postpartum PMTCT ARV exposure on Ugandan and Malawian PROMISE HIV-exposed uninfected children at 12, 24, and 48 months of age. Presented at: IAS 2017.

Citation

Jane C. Lindsey, Sc.D., Kathleen Malee, Ph.D., Pim Brouwers, Ph.D., Michael Hughes, Ph.D. Neurodevelopmental functioning in HIV-infected children before and after the introduction of highly active antiretroviral therapy (HAART). Presented at: XVI International AIDS Conference.

Citation

Paige L. Williams, Ph.D., Miguel Marino, Kathleen Malee, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P. Neurodevelopmental status and prenatal antiretroviral exposure in HIV-exposed uninfected infants. Presented at: XVII International AIDS Conference.

Citation

Michael Boivin, Miriam Chernoff, Jane Lindsey, Barbara Laughton, Katie McCarthy, Pim Brouwers, Patrick Jean-Philippe, Avy Violari, Mark Cotton, Paul Palumbo. Neuropsychological deficits of HIV-infected children in an African ART trial. Presented at: CROI 2016.

Citation

Michael Biovin, Miriam Chernoff, Bonnie Zimmer, Barbara Laughton, Celeste Joyce, Katie McCarthy, Pim Brouwers, Patrick Jean-Philippe, Sonia Lee, Joan Coetzee, Avy Violari, Mark Cotton, Paul Palumbo, P1104s Study Team. Neuropsychological performance in African children with HIV enrolled in a multi-site anti-retroviral clinical trial is poorer than non-infected children at those study sites. Presented at: 8th International Workshop on HIV Pediatrics; 2016 Jul 16.